for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca beats Q3 sales estimate, backs 2020 outlook

Nov 5 (Reuters) - AstraZeneca, the British drugmaker working on one of the world’s leading COVID-19 vaccine candidates, on Thursday beat third-quarter sales estimates on strong demand for its diverse portfolio of drugs during COVID-19 pandemic lockdowns and maintained its 2020 forecasts.

Reporting by Pushkala Aripaka, Ludwig Burger in Frankfurt; Editing by Bernard Orr

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up